Evidence map›Paper›PMID 27906093›Full record

ArticleStem cell research & therapy2016

microRNA -140-5p inhibits colorectal cancer invasion and metastasis by targeting ADAMTS5 and IGFBP5.

Lihui Yu, Ying Lu, Xiaocui Han, Wenyue Zhao, Jiazhi Li, Jun Mao, Bo Wang, Jie Shen, Shujun Fan, Lu Wang and 4 more

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Stem cell research & therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Lihui YuDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Ying LuDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Xiaocui HanDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Wenyue ZhaoDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Jiazhi LiDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Jun MaoDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Bo WangDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Jie ShenTeaching Laboratory of Morphology, Dalian Medical University, No. 9 West Section, Lvshun South Road, Dalian, 116044, People's Republic of China.
Shujun FanDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Lu WangDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Mei WangDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Lianhong LiDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Jianwu TangDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China.
Bo SongDepartment of Pathology, Dalian Medical University, Dalian, 116044, People's Republic of China. songbo9177@163.com.
Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) is one of the most common malignancies in the world. microRNA-140-5p (miR-140) has been shown to be involved in cartilage development and osteoarthritis (OA) pathogenesis. Some contradictions still exist concerning the role of miR-140 in tumor progression and metastasis, and the underlying mechanism is uncertain.

methodsImmunohistochemistry was performed to determine the expressions of ADAMTS5 and IGFBP5 in CRC tissues. Human CRC cell lines HCT116 and RKO were transfected with miR-140 mimic, inhibitor, or small interfering RNA (siRNA) against ADAMTS5 or IGFBP5, respectively, using oligofectamine or lipofectamine 2000. Scratch-wound assay and transwell migration and invasion assays were used to evaluate the effects of miR-140 on the capabilities of migration and invasion. The levels of miR-140 and ADAMTS5 and IGFBP5 mRNA were measured by quantitative real-time polymerase chain reaction (qRT-PCR). Western blot was performed to examine the expression of ADAMTS5 and IGFBP5 proteins.

resultsmiR-140 was significantly reduced, whereas ADAMTS5 and IGFBP5 were upregulated, in the human CRC tissues compared to the corresponding normal colorectal mucosa. miR-140 downregulation and ADAMTS5 or IGFBP5 overexpression were associated with the advanced TNM stage and distant metastasis of CRC. There was a reverse correlation between miR-140 levels and ADAMTS5 and IGFBP5 expression in CRC tissues. ADAMTS5 and IGFBP5 were downregulated by miR-140 at both the protein and mRNA levels in the CRC cell lines. The gain-of- and loss-of-function studies showed that miR-140 inhibited CRC cell migratory and invasive capacities at least partially via downregulating the expression of ADAMTS5 and IGFBP5.

conclusionsThese findings suggest that miR-140 suppresses CRC progression and metastasis, possibly through downregulating ADAMTS5 and IGFBP5. miR-140 might be a potential therapeutic candidate for the treatment of CRC.

Indexed as

Gene Expression Regulation, NeoplasticADAMTS5 ProteinAgedCell Line, TumorCell MovementColorectal NeoplasmsDisease ProgressionFemaleHCT116 CellsHumansInsulin-Like Growth Factor Binding Protein 5MaleMicroRNAsMiddle AgedNeoplasm InvasivenessNeoplasm MetastasisADAMTS5 ProteinADAMTS5 protein, humanInsulin-Like Growth Factor Binding Protein 5MicroRNAsMirn140 microRNA, humanOligoribonucleotides, AntisenseRNA, Small InterferingADAMTS5Colorectal cancerIGFBP5InvasionMetastasismicroRNA-140-5p

Identifiers

PMID27906093
PMCPMC5134063
OpenAlexW2557858903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.